NCT04125784View on ClinicalTrials.gov

Lipid Profile and Diabetes Mellitus in People With HIV

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 30, 2022

Study Completion Date

February 28, 2023

Conditions
HIV InfectionsDyslipidemiasDiabetes MellitusCardiovascular Risk Factor
Trial Locations (1)

1090

Schalk:Pichler Gruppenpraxis, Vienna

All Listed Sponsors
collaborator

Merck Gesellschaft mbH, Austria

INDUSTRY

lead

Moritz Oberndorfer

OTHER

NCT04125784 - Lipid Profile and Diabetes Mellitus in People With HIV | Biotech Hunter | Biotech Hunter